We examined the expression of OPG, RANKL, and PTHrP in patient samples from normal prostate tissue, prostate carcinoma, and metastatic prostate carcinoma tissues, as reported in the studies [47]–[55]. This evidence concerns the gene TNFSF11 and metastatic prostate carcinoma.